Top Menu

david_linetsky_headshot

One-on-One with Phreesia’s David Linetsky

Sponsored Content In this interview, DTC Perspectives’ Chairman, Bob Ehrlich, and Phreesia’s SVP of Life Sciences, David Linetsky, discuss how the patient experience has evolved rapidly during the COVID-19 pandemic, particularly as providers leverage digital patient intake solutions to enable safer contactless workflows. They will also explore the importance of aligning with platforms that are […]

Continue Reading 0
Bob Ehrlich

GSK Shingrix- Straight Talk

The new GSK campaign for its shingles vaccine is very interesting. They have coalesced their message around a very simple statement: “Shingles Doesn’t Care.” They are telling consumers that you can do everything right health wise and still get shingles. They are using a multimedia campaign which is well integrated in terms of creative approach. The 60-second […]

Continue Reading 0
Bob Ehrlich

Humira Improved

A very interesting DTC television ad, from AbbVie’s Humira, focuses on current users of their injectable pen. Humira users have sometimes complained about the pain as they inject, described as burning pain. Humira announced a reformulation which removed the citrate ingredient which was causing the pain. Is this a major improvement? Citrate was used as […]

Continue Reading 0
dv1954038

Genentech Releases Landmark Study on Health Inequity

After consistently seeing an underrepresentation of non-white patients in clinical research, Genentech decided to dig deeper as to why there is such enrollment inequity. According to an announcement from their website, the pharmaceutical manufacturer “undertook a landmark study to elevate the perspectives of these medically disenfranchised individuals and reveal how this long-standing inequity impacts their […]

Continue Reading 0
FDa-Logo-Blue-large-Small-01

Digital Health Center of Excellence Created by FDA

The FDA announced this week the creation of the Digital Health Center of Excellence for the Center for Devices and Radiological Health (CDRH). Its establishment is another step in the agency’s goal for modernizing digital health policies, regulatory approaches, and the advancement of digital health technology – such as mobile health devices, Software as a […]

Continue Reading 0
Bob Ehrlich

The Aging Male Problem- Urolift Solution

As we men age, the prostate gland grows about 2-2.5% a year. Eventually, most senior men get BPH which is a benign prostate condition that can lead to problems urinating as the enlarged prostate inhibits flow.So, what can men do to alleviate the problem? There are prescription drugs and surgical alternatives where the prostate can be […]

Continue Reading 0
ComputerTraining

Patient Access and Affordability Support in an Era of Virtuality

Today it’s more important than ever to help ensure that consumers can access and afford their medications. With the emergence of a global pandemic, what strategies and technologies can pharmaceutical manufacturers implement to help simplify and streamline the access process for consumers? The effectiveness of a pharmaceutical manufacturer’s access and reimbursement support program will have a […]

Continue Reading 0
ThinkstockPhotos-178114894

Innovation During the Pandemic: Opportunities and Needs at Point of Care to Prepare for Flu Season 2020-2021

The coronavirus pandemic has altered every facet of our lives. Everyday tasks suddenly became challenging and anything not deemed “essential” came to an abrupt halt. New terms and safety procedures are now part of our daily lives and even the most mundane contact with friends or extended family is accompanied by health and safety measures. […]

Continue Reading 0
Bob Ehrlich

DTC for Two Different Drugs in One Ad

Bristol Myers Squibb (BMS) has premiered a very interesting combo DTC ad featuring its two immunotherapy drugs Opdivo and Yervoy. The ad is for treatment of Non Small Cell Lung Cancer (NSCLC). What is very interesting is the approach of advertising two drugs in one ad. The FDA approved the combo for first line treatment […]

Continue Reading 0